Toremifene in the treatment of breast cancer

Figure 4 Incidence of serious vascular events in patients randomized to toremifene or tamoxifen adjuvant therapy in post-menopausal women[17]. 1: Total cerebrovascular events; 2: Stroke; 3: Transient ischaemic attack; 4: Total thromboembolic events; 5: Pulmonary embolism; 6: Deep vein thrombosis.